We examined the effects of folate (either alone or co-supplemented with Vitamin E) on endothelial function in hyperhomocysteinimic patients and correlated results with serum antioxidant capacity. A randomized trial was carried out in 30 young patients with recent acute myocardial infarction (AMI) and high plasma homocysteine concentrations. Intervention consisted of high doses of folate, either alone (group A) or in combination with Vitamin E (group B), for three months. Main outcome measures were endothelial function, serum antioxidant capacity, and homocysteinemia. Folic acid treatment reduced plasma homocysteine concentrations in both groups by 41% and, as compared with baseline values, was associated with a significant (P < 0.001) impro...
The mechanism by which homocysteine (Hcy) causes endothelial dysfunction is probably mediated by oxi...
Markedly or mildly elevated circulating homocysteine concentrations are associated with increased ri...
This study showed that short-term vitamin administration effectively reduced post-methionine load ho...
Homocysteine is a risk factor for coronary artery disease (CAD). Folic acid lowers homocysteine and ...
Background—Homocysteine is a risk factor for coronary artery disease (CAD), although a causal relati...
BACKGROUND: While folic acid (FA) reduces plasma homocysteine (Hcy), whether the simultaneous improv...
Hyperhomocysteinemia is associated with arterial hypertension and endothelial dysfunction in healthy...
Hyperhomocysteinemia is a risk factor for atherosclerosis and venous thrombosis, probably exerting i...
AbstractOBJECTIVESTo evaluate whether oral folic acid supplementation might improve endothelial func...
Hyperhomocysteinemia is a risk factor for arterial vascular disease and venous thrombosis. The patho...
We have previously shown that hyperhomocysteinaemia is common in elderly heart failure patients, and...
AbstractObjectivesWe evaluated the effect of therapy with folic acid and cobalamin on coronary endot...
Homocysteine is a sulfur-containing aminoacid produced during methionine metabolism. Since 1969 the ...
Abstract Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Sin...
The mechanism by which homocysteine (Hcy) causes endothelial dysfunction is probably mediated by oxi...
Markedly or mildly elevated circulating homocysteine concentrations are associated with increased ri...
This study showed that short-term vitamin administration effectively reduced post-methionine load ho...
Homocysteine is a risk factor for coronary artery disease (CAD). Folic acid lowers homocysteine and ...
Background—Homocysteine is a risk factor for coronary artery disease (CAD), although a causal relati...
BACKGROUND: While folic acid (FA) reduces plasma homocysteine (Hcy), whether the simultaneous improv...
Hyperhomocysteinemia is associated with arterial hypertension and endothelial dysfunction in healthy...
Hyperhomocysteinemia is a risk factor for atherosclerosis and venous thrombosis, probably exerting i...
AbstractOBJECTIVESTo evaluate whether oral folic acid supplementation might improve endothelial func...
Hyperhomocysteinemia is a risk factor for arterial vascular disease and venous thrombosis. The patho...
We have previously shown that hyperhomocysteinaemia is common in elderly heart failure patients, and...
AbstractObjectivesWe evaluated the effect of therapy with folic acid and cobalamin on coronary endot...
Homocysteine is a sulfur-containing aminoacid produced during methionine metabolism. Since 1969 the ...
Abstract Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Sin...
The mechanism by which homocysteine (Hcy) causes endothelial dysfunction is probably mediated by oxi...
Markedly or mildly elevated circulating homocysteine concentrations are associated with increased ri...
This study showed that short-term vitamin administration effectively reduced post-methionine load ho...